Skip to content
Esta página está disponible en españolCambiar →

Safe Bulkers (SB): which funds own it

Industrials →(by SIC code, unreviewed)Data as of Jun 30, 2026 (Q2 2026) · updated on Nov 5, 2026

A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.

Sections with a free account

1 concentrated manager holds it; combined they have held more shares for 2 quarters in a row (1 added, 0 trimmed). Its median weight in those portfolios is 0.0%.

Who owns Safe Bulkers?

Holders that filed a Schedule 13D or 13G with the SEC for owning more than 5% of the shares: Polys Hajioannou (13D/A filed Oct 14, 2025) and Polys Hajioannou (13D/A filed Sep 11, 2026). As of Jun 30, 2026, the largest holders reported on Form 13F were Goldman Sachs Group (4.0 million shares), BlackRock (3.6 million shares) and Renaissance Technologies (2.8 million shares).

Which institutions hold the most Safe Bulkers shares?

Per Form 13F filings as of Jun 30, 2026:

  1. 1. Goldman Sachs Group: 4.0 million shares
  2. 2. BlackRock: 3.6 million shares
  3. 3. Renaissance Technologies: 2.8 million shares
  4. 4. Fearnley Asset Management AS: 2.3 million shares
  5. 5. Two Sigma Investments: 1.8 million shares
  6. 6. State Street: 1.6 million shares
  7. 7. Acadian Asset Management: 1.6 million shares
  8. 8. LSV Asset Management: 1.6 million shares
  9. 9. UBS Group: 1.5 million shares
  10. 10. Arrowstreet Capital, Limited Partnership: 1.4 million shares

Sources:13D/A by Polys Hajioannou (Oct 14, 2025) ↗13D/A by Polys Hajioannou (Sep 11, 2026) ↗All of the company's proxy statements on EDGAR ↗

We hold 13D and 13G filings made since Dec 23, 2024: a holder above 5% that has not filed since then does not appear here.

Concentrated managers
1
All 13F: 158
Consensus
—
No score: it needs 5 or more concentrated managers
Price at Jun 30, 2026 (per 13F)
$6.31
-0.3% in the quarter · reported value ÷ shares, not the quote · See current quote ↗

Quarter flow (concentrated managers)

Change in managers (1 → 1): 0 opened · 0 exited = 0

Net flow in the quarter: +$32K (+5 K shares) · bought $32K and sold $0Shares concentrated managers added minus those they cut, valued at the 13F quarter-end implied price, not each trade's price. It is a different measure from the change in managers: the two can have opposite signs.

Accumulation: combined they have held more shares for 2 quarters in a row (1 added, 0 trimmed). It is the combined share count of those still holding it: one large buyer can outweigh many who trimmed.

Concentrated managers holding it

Up to 15, sorted by position value. The percentage is the weight in each manager's portfolio.

Largest holders of SB (all 13F filers)

The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.

Fundamentals

12-month figures to Dec 31, 2025 · balance sheet as of Dec 31, 2025.

Profitability
Operating margin
—
Net margin
—
ROE
4.6%
Growth
Revenue (TTM)
—
Revenue growth
—
Net income (TTM)
$38.6M
Balance sheet
Net debt / EBITDA
3.1x
Free cash flow (TTM)
—
Quality vs sector
—

This company's sector comes from its SIC code, unreviewed, or has too few comparable companies: we do not compare it with its sector.

Figures from the statements the company filed with the SEC (10-K, 10-Q). Free cash flow = operating cash flow − capital expenditures; empty if the company does not report capex. “Quality vs sector”: 0 to 100, the average of its percentiles in ROE, operating margin, free-cash-flow margin, revenue and earnings growth and net debt / EBITDA (at least 3 needed) against companies in its sector above $300M. How each figure is calculated

Shares outstanding: buybacks and dilution

Diluted shares by fiscal year (split-adjusted)

2025: 103.0 M

120.7 M0
20192025
1 year
−4.2%
3 years
−14.6%
5 years
+0.4%
Buybacks (FY 2025)
$11.0M
Share issuance
no data
Stock-based compensation
$150K
Dividends paid
no data

From the statements the company filed with the SEC (10-K). The change compares average diluted shares of each fiscal year, on today's basis: negative = it bought back more than it issued; positive = dilution. “No data” = the company does not report that item under a tag we can read; it does not mean zero.

Earnings quality and debt

Operating cash flow ÷ net income (12 months)
2.65
Interest coverage (operating income ÷ interest)
2.3 timesfiscal 2025
Debt due within 12 months
$44.8M0.31 times cash and investments
Debt maturities by year (note as of Dec 31, 2025)
  • Year 1$44.8M
  • Year 2$187M
  • Year 3$84.8M
  • Year 4$35.0M
  • Year 5$72.3M
  • Later$125M

From the figures the company filed with the SEC. Cash flow over net income near or above 1 means earnings are collected in cash; far below, that part is accounting. Coverage says how many times operating income pays the latest fiscal year's interest. Maturities come from the debt note of the latest annual report, counted from its closing date. “No data” never means zero.

Insiders (Form 4)

Officers and directors who bought (6 m)
no data
Amount (6 m)
no data
CEO/CFO bought (12 m)
No

Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.

Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →

Above 5% (13D/13G)

Disclosed stakes, with their amendments. A filing is not always a purchase: there are also reductions and changes of filing entity.

This list may be incomplete: we hold 13D and 13G filings made since Dec 23, 2024. A holder above 5% that has not filed anything since then is not shown here.

  • Polys Hajioannou43.8%13D · amendmentfiling ↗Event: Sep 9, 2026 · filed: Sep 11, 2026
  • Polys Hajioanno47.5%13D · amendmentfiling ↗Event: May 18, 2026 · filed: May 18, 2026
  • Polys Hajioannou48.45%13D · amendmentfiling ↗Event: Oct 14, 2025 · filed: Oct 14, 2025

Above 5% over time (13D/13G)

Each holder with its filings in order. History since December 2024.

This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗

Other Industrials stocks in managers' portfolios

Same sector and a similar number of concentrated managers holding them. It is a list to keep exploring, not a recommendation.

All of Industrials →

Follow SB for free

If someone reports a 5%+ stake, we email you (if you turn it on). And when you come back, see whether concentrated managers got in or out. No credit card.

Follow SB